Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cameron S. Field, Martin K. Hunn, Peter M. Ferguson, Christiane Ruedl, Lindsay R. Ancelet & Ian F. Hermans. (2018) Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model. OncoImmunology 7:1.
Read now
Read now
Norbert Galldiks, Martin Kocher & Karl-Josef Langen. (2017) Pseudoprogression after glioma therapy: an update. Expert Review of Neurotherapeutics 17:11, pages 1109-1115.
Read now
Read now
Fang Zhang, Chun-Lei Xu & Chun-Mei Liu. (2015) Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma. Drug Design, Development and Therapy 9, pages 2089-2100.
Read now
Read now
Yasmin Lassen-Ramshad, Jørgen B. B. Petersen, Anna Tietze, Per Borghammer, Anita Mahajan & Susan L. McGovern. (2015) Pseudoprogression after proton radiotherapy for pediatric low grade glioma. Acta Oncologica 54:9, pages 1701-1702.
Read now
Read now
Articles from other publishers (78)
Hanne Blakstad, Eduardo Erasmo Mendoza Mireles, Liv Cathrine Heggebø, Henriette Magelssen, Mette Sprauten, Tom Børge Johannesen, Einar Osland Vik-Mo, Henning Leske, Pitt Niehusmann, Karoline Skogen, Eirik Helseth, Kyrre Eeg Emblem & Petter Brandal. (2023) Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study. Neuro-Oncology Practice.
Crossref
Crossref
Thomas Zeyen, Daniel Paech, Johannes Weller, Niklas Schäfer, Theophilos Tzaridis, Cathrina Duffy, Louisa Nitsch, Matthias Schneider, Anna-Laura Potthoff, Joachim Peter Steinbach, Peter Hau, Uwe Schlegel, Clemens Seidel, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Pia Susan Zeiner, Ghazaleh Tabatabai, Norbert Galldiks, Walter Stummer, Elke Hattingen, Martin Glas, Alexander Radbruch, Ulrich Herrlinger & Christina Schaub. (2023) Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses. Journal of Neuro-Oncology 164:3, pages 607-616.
Crossref
Crossref
Elisabetta Schiavello, Veronica Biassoni, Giovanna Gattuso, Marta Podda, Stefano Chiaravalli, Francesco Barretta, Manila Antonelli, Loris De Cecco, Emilia Pecori, Lorenza Gandola & Maura Massimino. (2022) A homogeneous treatment for non-DIPG diffuse midline glioma. Tumori Journal 109:3, pages 269-275.
Crossref
Crossref
Laura Evangelista, Paolo Artoli, Paola Bartoletti, Antonio Bignotto, Federica Menegatti, Marco Frigo, Stefania Antonia Sperti, Laura Vendramin & Diego Cecchin. 2023. Radiology‐Nuclear Medicine Diagnostic Imaging. Radiology‐Nuclear Medicine Diagnostic Imaging
788
813
.
Ethan A Wetzel, Matthew J Farrell, Blaine S C Eldred, Vicki Liu, Ishan Saha, Serendipity Zapanta Rinonos, Terry Prins, Tie Li, Minsong Cao, John Hegde, Tania Kaprealian, Negar Khanlou, Linda M Liau, Phioanh Leia Nghiemphu, Timothy Francis Cloughesy, Robert A Chong, Benjamin M Ellingson & Albert Lai. (2023)
Retrospective examination of pseudoprogression in
IDH
mutant gliomas
. Neuro-Oncology Advances 5:1.
Crossref
Crossref
Xun Xu, Yuan Liang, Ilgiz Gareev, Yanchao Liang, Rui Liu, Ning Wang & Guang Yang. (2022) LncRNA as potential biomarker and therapeutic target in glioma. Molecular Biology Reports 50:1, pages 841-851.
Crossref
Crossref
Shah Islam, Melanie A. Morrison & Adam D. Waldman. 2023. Functional Neuroradiology. Functional Neuroradiology
433
457
.
Arastoo Vossough & Seyed Ali Nabavizadeh. 2023. Functional Neuroradiology. Functional Neuroradiology
311
343
.
Julia V. Velikina, Youngkyoo Jung, Aaron S. Field & Alexey A. Samsonov. (2022) High‐resolution dynamic susceptibility contrast perfusion imaging using higher‐order temporal smoothness regularization. Magnetic Resonance in Medicine 89:1, pages 112-127.
Crossref
Crossref
Peng Du, Hongyi Chen, Kun Lv & Daoying Geng. (2022) A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas. Journal of Clinical Medicine 11:13, pages 3802.
Crossref
Crossref
Lonika Majithia, Steve Walston, Michael Guiou, Nilendu Gupta & Arnab Chakravarti. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
257
267
.
Zachary S. Mayo, Ahmed Halima, Samuel T. Chao, Simon S. Lo, Joseph A. Bovi & John H. Suh. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
809
819
.
Jun Qiu, Zhen-Chao TaoKe-Xue Deng, Peng Wang, Chuan-Yu Chen, Fang Xiao, Yi Luo, Shu-Ya Yuan, Hao Chen & Huan Huang. (2021) Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis. Chinese Medical Journal 134:21, pages 2535-2543.
Crossref
Crossref
Monica Celli, Paola Caroli, Elena Amadori, Donatella Arpa, Lorena Gurrieri, Giulia Ghigi, Patrizia Cenni, Giovanni Paganelli & Federica Matteucci. (2021) Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy. Frontiers in Oncology 11.
Crossref
Crossref
M. Kim, J.E. Park, K. Emblem, A Bjørnerud & H.S. Kim. (2021) Vessel Type Determined by Vessel Architectural Imaging Improves Differentiation between Early Tumor Progression and Pseudoprogression in Glioblastoma. American Journal of Neuroradiology 42:4, pages 663-670.
Crossref
Crossref
Z. Sui, X. Zhang, H. Li, D. Xu & G. Li. (2020) Magnetic resonance imaging evaluation of brain glioma before postoperative radiotherapy. Clinical and Translational Oncology 23:4, pages 820-826.
Crossref
Crossref
Clara Le Fèvre, Jean-Marc Constans, Isabelle Chambrelant, Delphine Antoni, Caroline Bund, Benjamin Leroy-Freschini, Roland Schott, Hélène Cebula & Georges Noël. (2021) Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers. Critical Reviews in Oncology/Hematology 159, pages 103230.
Crossref
Crossref
Anthony Patrizz, Antonio Dono, Ping Zhu, Nitin Tandon, Leomar Y. Ballester & Yoshua Esquenazi. (2021) Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?. Journal of Neuro-Oncology 152:1, pages 163-172.
Crossref
Crossref
Lee Ming, Tan Gek San, Tham Chee Kian & Tony Lim Kiat-Hon. (2020) Detection of IDH mutations in cerebrospinal fluid: A discussion of liquid biopsy in neuropathology. Archives of Pathology and Clinical Research 4:1, pages 011-023.
Crossref
Crossref
Sebastian F. Winter, Eugene J. Vaios, Alona Muzikansky, Maria Martinez-Lage, Marc R. Bussière, Helen A. Shih, Jay Loeffler, Philipp Karschnia, Franziska Loebel, Peter Vajkoczy & Jorg Dietrich. (2020) Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis. The Oncologist 25:8, pages e1221-e1232.
Crossref
Crossref
Inês Alves, Istvan Bodi, Jozef Jarosz, Henry Mandeville, Bassel Zebian & Fernando Carceller. (2020) Radiological pseudoprogression post‐radiotherapy in a child with pineal germ cell tumour. Pediatric Blood & Cancer 67:7.
Crossref
Crossref
Lance T. Hall, Benjamin Titz, Nishanta Baidya, Anja G. van der Kolk, H. Ian Robins, Mario Otto, Scott B. Perlman, Jamey P. Weichert & John S. Kuo. (2019) [124I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors. Molecular Imaging and Biology 22:2, pages 434-443.
Crossref
Crossref
Meiyu Li, Hailiang Tang, Michael D. Chan, Xiaobo Zhou & Xiaohua Qian. (2020) DC‐AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet. Medical Physics 47:3, pages 1139-1150.
Crossref
Crossref
Ji Eun Park & Ho Sung Kim. (2020) Current Applications and Future Perspectives of Brain Tumor Imaging. Journal of the Korean Society of Radiology 81:3, pages 467.
Crossref
Crossref
Yu.Yu. Trunin, A.V. Golanov, A.N. Konovalov & I.N. Pronin. (2020) Pseudoprogression of intracranial pilocytic astrocytomas and other low-grade gliomas. Literature review and case report. Voprosy neirokhirurgii imeni N.N. Burdenko 84:6, pages 105.
Crossref
Crossref
Fatih M. Uckun, Sanjive Qazi, Larn Hwang & Vuong N. Trieu. (2019) Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up. Cancers 11:12, pages 1892.
Crossref
Crossref
Sergio Vera, Mariana Sinning, Marcela Vergara, David Lemus & Carlos Rosas. (2019) Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study. Journal of Neuro-Oncology 145:2, pages 233-239.
Crossref
Crossref
Jamie D. Costabile, John A. Thompson, Elsa Alaswad & D. Ryan Ormond. (2019) Biopsy Confirmed Glioma Recurrence Predicted by Multi-Modal Neuroimaging Metrics. Journal of Clinical Medicine 8:9, pages 1287.
Crossref
Crossref
Luz M. Cumba Garcia, Timothy E. Peterson, Mario A. Cepeda, Aaron J. Johnson & Ian F. Parney. (2019) Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma. Frontiers in Oncology 9.
Crossref
Crossref
Alexandre Bani-Sadr, Omer Faruk Eker, Lise-Prune Berner, Roxana Ameli, Marc Hermier, Marc Barritault, David Meyronet, Jacques Guyotat, Emmanuel Jouanneau, Jerome Honnorat, François Ducray & Yves Berthezene. (2019) Conventional MRI radiomics in patients with suspected early- or pseudo-progression. Neuro-Oncology Advances 1:1.
Crossref
Crossref
Małgorzata Grabowska, Bartosz F. Grześkowiak, Kosma Szutkowski, Dariusz Wawrzyniak, Paweł Głodowicz, Jan Barciszewski, Stefan Jurga, Katarzyna Rolle & Radosław Mrówczyński. (2019) Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme. PLOS ONE 14:3, pages e0213852.
Crossref
Crossref
Joel M. Cherlow, Dennis W.W. Shaw, Linda R. Margraf, Daniel C. Bowers, Jie Huang, Maryam Fouladi, Arzu Onar-Thomas, Tianni Zhou, Ian F. Pollack, Amar Gajjar, Sandy K. Kessel, Patricia L. Cullen, Kevin McMullen, John C. Wellons & Thomas E. Merchant. (2019) Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221. International Journal of Radiation Oncology*Biology*Physics 103:4, pages 861-868.
Crossref
Crossref
Michael Dworkin, William Mehan, Andrzej Niemierko, Sophia C. Kamran, Nayan Lamba, Jorg Dietrich, Maria Martinez-Lage, Kevin S. Oh, Tracy T. Batchelor, Patrick Y. Wen, Jay S. Loeffler & Helen A. Shih. (2018) Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. Journal of Neuro-Oncology 142:1, pages 69-77.
Crossref
Crossref
Jung Youn Kim, Ji Eun Park, Youngheun Jo, Woo Hyun Shim, Soo Jung Nam, Jeong Hoon Kim, Roh-Eul Yoo, Seung Hong Choi & Ho Sung Kim. (2019) Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients. Neuro-Oncology 21:3, pages 404-414.
Crossref
Crossref
Derek R. Johnson, Julie B. Guerin, Michael W. Ruff, Shanna Fang, Christopher H. Hunt, Jonathan M. Morris, P. Pearse Morris & Timothy J. Kaufmann. (2019) Glioma response assessment: Classic pitfalls, novel confounders, and emerging imaging tools. The British Journal of Radiology 92:1094, pages 20180730.
Crossref
Crossref
Benita Tamrazi, Kshitij Mankad, Marvin Nelson & Felice D’Arco. (2018) Current concepts and challenges in the radiologic assessment of brain tumors in children: part 2. Pediatric Radiology 48:13, pages 1844-1860.
Crossref
Crossref
Markus Nilsson, Elisabet Englund, Filip Szczepankiewicz, Danielle van Westen & Pia C. Sundgren. (2018) Imaging brain tumour microstructure. NeuroImage 182, pages 232-250.
Crossref
Crossref
Kenji Miyata, Toshinori Hori, Yasuto Shimomura, Masahiro Joko, Masakazu Takayasu & Akihisa Okumura. (2018) Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma. Child's Nervous System 34:11, pages 2305-2308.
Crossref
Crossref
Michael H. Soike, Emory R. McTyre, Nameeta Shah, Ralph B. Puchalski, Jordan A. Holmes, Anna K. Paulsson, Lance D. Miller, Christina K. Cramer, Glenn J. Lesser, Roy E. Strowd, William H. Hinson, Ryan T. Mott, Annette J. Johnson, Hui-Wen Lo, Adrian W. Laxton, Stephen B. Tatter, Waldemar Debinski & Michael D. Chan. (2018) Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?. Neuroradiology 60:10, pages 1043-1051.
Crossref
Crossref
Whitney B. Pope & Garth Brandal. (2018) Conventional and advanced magnetic resonance imaging in patients with high-grade glioma. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 62:3.
Crossref
Crossref
K. Ina Ly & Elizabeth R. Gerstner. (2018) The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies. Current Treatment Options in Oncology 19:8.
Crossref
Crossref
Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin & Steven P. Rowe. (2018) Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms. Journal of Nuclear Medicine 59:6, pages 871-877.
Crossref
Crossref
Brendan J. McCullough & John W. Henson. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
715
727
.
Cassandra Verheul, Anne Kleijn & Martine L.M. Lamfers. 2018. Cerebrospinal Fluid in Neurologic Disorders. Cerebrospinal Fluid in Neurologic Disorders
139
169
.
Kangchu Li, Keying Zhang, Shenglong Xu, Xiaowu Wang, Yongchun Zhou, Yan Zhou, Peng Gao, Jiajin Lin, Guirong Ding & Guozhen Guo. (2018) EMP-induced BBB-disruption enhances drug delivery to glioma and increases treatment efficacy in rats. Bioelectromagnetics 39:1, pages 60-67.
Crossref
Crossref
Nestor Martínez-Amador, Julio Jiménez-Bonilla, Isabel Martínez-Rodríguez, Maria De Arcocha-Torres, Remedios Quirce, Francisco J. Gómez-de la Fuente, Jorge L. López-Defilló & Ignacio Banzo. (2017) Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors’ recurrence versus post-therapeutic changes. Nuclear Medicine Communications 38:12, pages 1125-1132.
Crossref
Crossref
Qian Xu, Qi Liu, Haitao Ge, Xinting Ge, Jiangfen Wu, Jianxun Qu & Kai Xu. (2017) Tumor recurrence versus treatment effects in glioma. Medicine 96:50, pages e9332.
Crossref
Crossref
Carmen Balaña, Jaume Capellades, Estela Pineda, Anna Estival, Josep Puig, Sira Domenech, Eugenia Verger, Teresa Pujol, Maria Martinez-García, Laura Oleaga, JoseMaria Velarde, Carlos Mesia, Rafael Fuentes, Jordi Marruecos, Sonia Del Barco, Salvador Villà, Cristina Carrato, Oscar Gallego, Miguel Gil-Gil, Jordi Craven-Bartle & Francesc Alameda. (2017) Pseudoprogression as an adverse event of glioblastoma therapy. Cancer Medicine 6:12, pages 2858-2866.
Crossref
Crossref
Derek S. Tsang, Erin S. Murphy, John T. LucasJr.Jr., Pagona Lagiou, Sahaja Acharya & Thomas E. Merchant. (2017) Pseudoprogression in pediatric low-grade glioma after irradiation. Journal of Neuro-Oncology 135:2, pages 371-379.
Crossref
Crossref
Lisbeth Marner, Otto M. Henriksen, Michael Lundemann, Vibeke Andrée Larsen & Ian Law. (2016) Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective. Clinical and Translational Imaging 5:2, pages 135-149.
Crossref
Crossref
Sachin R. Jhawar, Ann W. Silk & Sharad Goyal. (2017) Pseudoprogression of a spinal metastasis after stereotactic ablative body radiation therapy and immune checkpoint therapy. Practical Radiation Oncology 7:2, pages 109-112.
Crossref
Crossref
Lei Qin, Xiang Li, Amanda Stroiney, Jinrong Qu, Jeffrey Helgager, David A. Reardon & Geoffrey S. Young. (2017) Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma. Neuroradiology 59:2, pages 135-145.
Crossref
Crossref
Domenico Aquino, Andrea Gioppo, Gaetano Finocchiaro, Maria Grazia Bruzzone & Valeria Cuccarini. (2017) MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives. Journal of Immunology Research 2017, pages 1-16.
Crossref
Crossref
Norbert Galldiks, Ian Law, Whitney B. Pope, Javier Arbizu & Karl-Josef Langen. (2017) The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. NeuroImage: Clinical 13, pages 386-394.
Crossref
Crossref
Gautham Gampa, Shruthi Vaidhyanathan, Brynna Wilken-Resman, Karen E. Parrish, Svetomir N. Markovic, Jann N. Sarkaria & William F. Elmquist. (2016) Challenges in the Delivery of Therapies to Melanoma Brain Metastases. Current Pharmacology Reports 2:6, pages 309-325.
Crossref
Crossref
Xiaohua Qian, Hua Tan, Jian Zhang, Weilin Zhao, Michael D. Chan & Xiaobo Zhou. (2016) Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation. Medical Physics 43:11, pages 5889-5902.
Crossref
Crossref
Howard E. Morgan, Maxwell C. McDonald & J. Ben Wilkinson. (2016) Subclinical recurrence of anaplastic astrocytoma: Demonstrating the difficulty in distinguishing progression from pseudoprogression. Applied Radiation Oncology, pages 32-35.
Crossref
Crossref
Xiaohua Qian, Hua Tan, Jian Zhang, Keqin Liu, Tielin Yang, Maode Wang, Waldemar Debinskie, Weilin Zhao, Michael D. Chan & Xiaobo Zhou. (2016) Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study. Oncotarget 7:34, pages 55377-55394.
Crossref
Crossref
Ellen G. Hoeffner. (2016) Central Nervous System Complications of Oncologic Therapy. Hematology/Oncology Clinics of North America 30:4, pages 899-920.
Crossref
Crossref
Fernando Carceller, Lucy A. Fowkes, Komel Khabra, Lucas Moreno, Frank Saran, Anna Burford, Alan Mackay, David T. W. Jones, Volker Hovestadt, Lynley V. Marshall, Sucheta Vaidya, Henry Mandeville, Neil Jerome, Leslie R. Bridges, Ross Laxton, Safa Al-Sarraj, Stefan M. Pfister, Martin O. Leach, Andrew D. J. Pearson, Chris Jones, Dow-Mu Koh & Stergios Zacharoulis. (2016) Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma. Journal of Neuro-Oncology 129:1, pages 109-121.
Crossref
Crossref
Amarnath Jena, Sangeeta Taneja, Aashish Gambhir, Anil Kumar Mishra, Maria Mathew D'souza, Sapna Manocha Verma, Puja Panwar Hazari, Pradeep Negi, Ganesh Krishna Rao Jhadav & Shanti Kumar Sogani. (2016) Glioma Recurrence Versus Radiation Necrosis. Clinical Nuclear Medicine 41:5, pages e228-e236.
Crossref
Crossref
Cecelia Elizabeth Gzell, Helen R. Wheeler, Philip McCloud, Marina Kastelan & Michael Back. (2016) Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma. Journal of Neuro-Oncology 128:1, pages 67-74.
Crossref
Crossref
Keisuke MIYAKE, Daisuke OGAWA, Masaki OKADA, Tetsuhiro HATAKEYAMA & Takashi TAMIYA. (2016) Usefulness of positron emission tomographic studies for gliomas. Neurologia medico-chirurgica 56:7, pages 396-408.
Crossref
Crossref
Whitney B. Pope, Ibrahim Djoukhadar & Alan Jackson. 2016. Gliomas. Gliomas
27
50
.
Nancy Ann Oberheim Bush, Soonmee Cha, Susan M. Chang & Jennifer L. Clarke. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
681
695
.
Brendan J. McCullough & John W. Henson. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
667
680
.
Lonika Majithia, Steve Walston, Michael Guiou, Nilendu Gupta & Arnab Chakravarti. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
231
241
.
Norbert Galldiks, Karl-Josef Langen & Whitney B. Pope. (2015) From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?. Neuro-Oncology 17:11, pages 1434-1444.
Crossref
Crossref
Douglas R. Taylor & Jason A. Weaver. (2015) Tumor pseudoprogression of spinal metastasis after radiosurgery: a novel concept and case reports. Journal of Neurosurgery: Spine 22:5, pages 534-539.
Crossref
Crossref
P. Werner, H. Barthel, A. Drzezga & O. Sabri. (2015) Current status and future role of brain PET/MRI in clinical and research settings. European Journal of Nuclear Medicine and Molecular Imaging 42:3, pages 512-526.
Crossref
Crossref
Marta Penas-Prado, Kenneth R. Hess, Michael J. Fisch, Lore W. Lagrone, Morris D. Groves, Victor A. Levin, John F. De Groot, Vinay K. Puduvalli, Howard Colman, Gena Volas-Redd, Pierre Giglio, Charles A. Conrad, Michael E. Salacz, Justin D. Floyd, Monica E. Loghin, Sigmund H. Hsu, Javier Gonzalez, Eric L. Chang, Shiao Y. Woo, Anita Mahajan, Kenneth D. Aldape, W. K. Alfred Yung & Mark R. Gilbert. (2015) Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro-Oncology 17:2, pages 266-273.
Crossref
Crossref
Kimberly A. Foster, William J. Ares, Ian F. Pollack & Regina I. Jakacki. (2015) Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas. Pediatric Blood & Cancer 62:2, pages 240-245.
Crossref
Crossref
Tuva R. Hope, Jonas Vardal, Atle Bjørnerud, Christopher Larsson, Marius R. Arnesen, Raimo A. Salo & Inge R. Groote. (2015) Serial diffusion tensor imaging for early detection of radiation-induced injuries to normal-appearing white matter in high-grade glioma patients. Journal of Magnetic Resonance Imaging 41:2, pages 414-423.
Crossref
Crossref
Cameron J. Koch, Robert A. Lustig, Xiang-Yang Yang, Walter T. Jenkins, Ronald L. Wolf, Maria Martinez-Lage, Arati Desai, Dewight Williams & Sydney M. Evans. (2014) Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients. Translational Oncology 7:6, pages 752-758.
Crossref
Crossref
John P. Kirkpatrick & John H. Sampson. (2014) Recurrent Malignant Gliomas. Seminars in Radiation Oncology 24:4, pages 289-298.
Crossref
Crossref
J. M. Kros, D. M. Mustafa, L. J. M. Dekker, P. A. E. Sillevis Smitt, T. M. Luider & P.-P. Zheng. (2014) Circulating glioma biomarkers. Neuro-Oncology.
Crossref
Crossref
Barbara J. O’Brien & Rivka R. Colen. (2014) Post-Treatment Imaging Changes in Primary Brain Tumors. Current Oncology Reports 16:8.
Crossref
Crossref
Paulo Linhares, Bruno Carvalho, Rita Figueiredo, Rui M. Reis & Rui Vaz. (2013) Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation. Journal of Oncology 2013, pages 1-9.
Crossref
Crossref